Aranesp, Epogen and Procrit–Increase the risk of death

It’s fascinating, these drugs have been around for about 15 years. They were never thought to improve disease survival and were marketed aggressively directly to consumers as well as physicians as medications that help people cope with their treatment. (“Ask your doctor about ………”) Now we find “they can increase the risk of death and tumor growth.”

The companies involved have made billions of dollars on these medications, they were expensive and given on a regular basis throughout the treatment cycle. It’s hard to believe that no one along the way seriously considered the possibility that the drugs might worsen prognosis–I know it was a consideration in hematologic malignancy.

In other countries their use was limited because of their cost and because the countries negotiated their prices were lower.

Powered by Zoundry

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s